Skip to main content
SpringerLink
Log in

Exploring the cause of drug resistance by the detrimental missense mutations in KIT receptor: computational approach

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

In this work, we computationally identified the most detrimental missense mutations of KIT receptor causing gastrointestinal stromal tumors and analyzed the drug resistance of these missense mutations. Out of 31 missense mutations, 19 variants were commonly found less stable, deleterious and damaging by I-Mutant 2.0, SIFT and PolyPhen programs, respectively. Subsequently, we performed modeling of these 19 variants to understand their change in conformations with respect to native KIT receptor by computing their RMSD. Further, the native and 19 mutants were docked with the drug ‘Imatinib’ to explain the drug resistance of these detrimental missense mutations. Among the 19 mutants, we found by docking studies that 12 mutants, namely, F584C, F584L, V654A, L656P, T670I, R804W, D816F, D816V, D816Y, N822K, Y823D and E839K had less binding affinity with Imatinib than the native type. Finally, we analyzed that the loss of binding affinity of these 12 mutants, was due to altered flexibility in their binding amino acids with Imatinib as compared with native type by normal mode analysis. In our work, we found the novel data that the majority of the drug-binding amino acids in those 12 mutants had encountered loss of flexibility, which could be the theoretical basis for the cause of drug insensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Bauer S, Hartmann JT, de WM, Lang H, Grabellus F, Antoch G, Niebel W, Erhard J, Ebeling P, Zeth M (2005) Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Int J Cancer 117:316–325

  • Bauer S, Yu LK, Demetri GD, Fletcher JA (2006) Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor. Cancer Res 66(18):9153–9161

    Article  PubMed  CAS  Google Scholar 

  • Bava KA, Gromiha MM, Uedaira H, Kitajima K, Sarai A (2004) ProTherm, version 4.0: thermodynamic database for proteins and mutants. Nucleic Acids Res 32:120–121

    Article  CAS  Google Scholar 

  • Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28(1):235–242

    Article  PubMed  CAS  Google Scholar 

  • Blechman JM, Lev S, Barg J, Eisenstein M, Vaks B, Vogel Z, Givol D, Yarden Y (1995) The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80:103–113

    Article  PubMed  CAS  Google Scholar 

  • Blume-Jensen P, Hunter T (2001) Oncogenic kinase signaling. Nature 411:355–365

    Article  PubMed  CAS  Google Scholar 

  • Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O’Donovan C, Phan I, Pilbout S, Schneider M (2003) The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 31(1):365–370

    Article  PubMed  CAS  Google Scholar 

  • Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33:306–310

    Article  CAS  Google Scholar 

  • Carlson HA, McCammon JA (2000) Accommodating protein flexibility in computational drug design. Mol Pharmacol 57:213–218

    PubMed  CAS  Google Scholar 

  • Cavallo A, Martin AC (2005) Mapping SNPs to protein sequence and structure data. Bioinformatics 21(8):1443–1450

    Article  PubMed  CAS  Google Scholar 

  • Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML (2004) A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res 64(17):5913–5919

    Article  PubMed  CAS  Google Scholar 

  • Chen LL, Sabripour M, Andtbacka RH, Patel SR, Feig BW, Macapinlac HA, Choi H, Wu EF, Frazier ML, Benjamin RS (2005) Imatinib resistance in gastrointestinal stromal tumors. Curr Oncol Rep 7(4):293–299

    Article  PubMed  CAS  Google Scholar 

  • Ciccarelli FD, Acciarito A, Alberti S (2000) Large and diverse numbers of human diseases with HIKE mutations. Hum Mol Genet 9(6):1001–1007

    Article  PubMed  CAS  Google Scholar 

  • Connolly ML (1983a) Solvent-accessible surfaces of proteins and nucleic acids. Science 221(4612):709–713

    Article  PubMed  CAS  Google Scholar 

  • Connolly ML (1983b) Analytical molecular surface calculation. J Appl Cryst 16:548–558

    Article  CAS  Google Scholar 

  • Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B, Prenen H, Roesel J, Hagemeijer A, Van Oosterom A, Marynen P (2005) Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. Gastroenterology 128(2):270–279

    Article  PubMed  CAS  Google Scholar 

  • Delarue M, Dumas P (2004) On the use of low-frequency normal modes to enforce collective movements in refining macromolecular structural models. Proc Natl Acad Sci USA 101(18):6957–6962

    Article  PubMed  CAS  Google Scholar 

  • Duhovny D, Nussinov R, Wolfson HJ (2002) Efficient unbound docking of rigid molecules. In: Gusfield D et al (eds) Proceedings of the second workshop on algorithms in bioinformatics (WABI) Lecture Notes in Computer Science, vol 2452, Springer, Rome, Italy, pp 185–200

  • Engelman JA, Settleman J (2008) Acquired resistance to tyrosine kinase inhibitors during cancer therapy. Curr Opin Genet Dev 18:73–79

    Article  PubMed  CAS  Google Scholar 

  • Fletcher JA, Rubin BP (2007) KIT mutations in GIST. Curr Opin Genet Dev 17(1):3–7

    Article  PubMed  CAS  Google Scholar 

  • Gajiwala KS, Wu JC, Christensen J, Deshmukh GD, Diehl W, Dinitto JP, English JM, Greig MJ, He YA, Jacques SL, Lunney EA, McTigue M, Molina D, Quenzer T, Wells PA, Yu X, Zhang Y, Zou A, Emmett MR, Marshall AG, Zhang HM, Demetri GD (2009) KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients. Proc Natl Acad Sci USA 106(5):1542–1547

    Article  PubMed  Google Scholar 

  • Growney JD, Clark JJ, Adelsperger J, Stone R, Fabbro D, Griffin JD, Gilliland DG (2005) Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412. Blood 106(2):721–724

    Article  PubMed  CAS  Google Scholar 

  • Guo T, Agaram NP, Wong GC, Hom G, D’Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR (2007) Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor. Clin Cancer Res 13(16):4874–4881

    Article  PubMed  CAS  Google Scholar 

  • Gupta P, Tewari M, Shukla HS (2008) Gastrointestinal stromal tumor. Surg Oncol 17(2):129–138

    Article  PubMed  Google Scholar 

  • Han JH, Kerrison N, Chothia C, Teichmann SA (2006) Divergence of interdomain geometry in two-domain proteins. Structure 14(5):935–945

    Article  PubMed  CAS  Google Scholar 

  • Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, Eisenberg BL, von Mehren M, Fletcher CD, Sandau K, McDougall K, Ou WB, Chen CJ, Fletcher JA (2006) Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol 24(29):4764–4774

    Article  PubMed  CAS  Google Scholar 

  • Hinkle A, Tobacman LS (2003) Folding and function of the troponin tail domain. Effects of cardiomyopathic troponin T mutations. J Biol Chem 278(1):506–513

    Article  PubMed  CAS  Google Scholar 

  • Jonathan Fletcher A, Brian Rubin P (2007) KIT mutations in GIST. Curr Opin Genet Dev 17:3–7

    Article  PubMed  CAS  Google Scholar 

  • Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC (2004) KIT mutations are common in testicular Seminomas. Am J Pathol 164(1):305–313

    PubMed  CAS  Google Scholar 

  • Kim HJ, Lim SJ, Park K, Yuh YJ, Jang SJ, Choi J (2005) Multiple gastrointestinal stromal tumors with a germline c-kit mutation. Pathol Int 55(10):655–659

    Article  PubMed  CAS  Google Scholar 

  • Lemmon MA, Pinchasi D, Zhou M, Lax I, Schlessinger J (1997) Kit receptor dimerization is driven by bivalent binding of stem cell factor. J Biol Chem 272:6311–6317

    Article  PubMed  CAS  Google Scholar 

  • Lev S, Yarden Y, Givol D (1992) Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. J Biol Chem 267:15970–15977

    PubMed  CAS  Google Scholar 

  • Lindahl E, Azuara C, Koehl P, Delarue M (2006) NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all-atom normal mode analysis. Nucleic Acids Res 34:52–56

    Article  CAS  Google Scholar 

  • López G, Valencia A, Tress ML (2007) Firestar—prediction of functionally important residues using structural templates and alignment reliability. Nucleic Acids Res 35:573–577

    Article  Google Scholar 

  • Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, McMahon G, Longley BJ (2002) The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99(5):1741–1744

    Article  PubMed  CAS  Google Scholar 

  • McLean SR, Gana-Weisz M, Hartzoulakis B, Frow R, Whelan J, Selwood D, Boshoff C (2005) Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala. Mol Cancer Ther 4(12):2008–2015

    Article  PubMed  CAS  Google Scholar 

  • Mol CD, Dougan DR, Schneider TR, Skene RJ, Kraus ML, Scheibe DN, Snell GP, Zou H, Sang BC, Wilson KP (2004) Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase. J Biol Chem 279(30):31655–31663

    Article  PubMed  CAS  Google Scholar 

  • Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11(5):863–874

    Article  PubMed  CAS  Google Scholar 

  • Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13):3812–3814

    Article  PubMed  CAS  Google Scholar 

  • Nishida T, Kanda T, Nishitani A, Takahashi T, Nakajima K, Ishikawa T, Hirota S (2008) Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor. Cancer Sci 99(4):799–804

    Article  PubMed  CAS  Google Scholar 

  • Parthasarathy S, Murthy MR (2000) Protein thermal stability: insights from atomic displacement parameters (B values). Protein Eng 13:9–13

    Article  PubMed  CAS  Google Scholar 

  • Philo JS, Wen J, Wypych J, Schwartz MG, Mendiaz EA, Langley KE (1996) Human stem cell factor dimer forms a complex with two molecules of the extracellular domain of its receptor, Kit. J Biol Chem 271:6895–6902

    Article  PubMed  CAS  Google Scholar 

  • Rajasekaran R, George Priya Doss C, Sudandiradoss C, Ramanathan K, Purohit R, Sethumadhavan R (2008a) Effect of deleterious nsSNP on the HER2 receptor based on stability and binding affinity with herceptin: a computational approach. C R Biol 331(6):409–417

    Article  PubMed  CAS  Google Scholar 

  • Rajasekaran R, Priya Doss CG, Sudandiradoss C, Ramanathan K, Sethumadhavan R (2008b) In silico analysis of structural and functional consequences in p16INK4A by deleterious nsSNPs associated CDKN2A gene in malignant melanoma. Biochimie 90(10):1523–1529

    Article  PubMed  CAS  Google Scholar 

  • Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30(17):3894–3900

    Article  PubMed  CAS  Google Scholar 

  • Ringe D, Petsko GA (1986) Study of protein dynamics by X-ray diffraction. Methods Enzymol 131:389–433

    Article  PubMed  CAS  Google Scholar 

  • Roberts KG, Odell AF, Byrnes EM, Baleato RM, Griffith R, Lyons AB, Ashman LK (2007) Resistance to c-KIT kinase inhibitors conferred by V654A mutation. Mol Cancer Ther 6(3):1159–1166

    Article  PubMed  CAS  Google Scholar 

  • Roskoski R Jr (2005) Structure and regulation of Kit protein-tyrosine kinase—the stem cell factor receptor. Biochem Biophys Res Commun 338(3):1307–1315

    Article  PubMed  CAS  Google Scholar 

  • Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103:211–225

    Article  PubMed  CAS  Google Scholar 

  • Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res 33:363–367

    Article  CAS  Google Scholar 

  • Sharma S, Ding F, Nie H, Watson D, Unnithan A, Lopp J, Pozefsky D, Dokholyan NV (2006) iFold: a platform for interactive folding simulations of proteins. Bioinformatics 22(21):2693–2694

    Article  PubMed  CAS  Google Scholar 

  • Suhre K, Sanejouand YH (2004) ElNémo: a normal mode web-server for protein movement analysis and the generation of templates for molecular replacement. Nucleic Acids Res 32:610–614

    Article  CAS  Google Scholar 

  • Tan A, Westerman D, McArthur GA, Lynch K, Waring P, Dobrovic A (2006) Sensitive detection of KIT D816V in patients with mastocytosis. Clin Chem 52(12):2250–2257

    Article  PubMed  CAS  Google Scholar 

  • Teng S, Madej T, Panchenko A, Alexov E (2009) Modeling effects of human single nucleotide polymorphisms on protein–protein interactions. Biophys J 96(6):2178–2188

    Article  PubMed  CAS  Google Scholar 

  • Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–212

    Article  PubMed  CAS  Google Scholar 

  • Varfolomeev SD, Uporov IV, Fedorov EV (2002) Bioinformatics and molecular modeling in chemical enzymology. Active sites of hydrolases. Biochemistry (Mosc) 67(10):1099–1108

    Article  CAS  Google Scholar 

  • Weisberg E, Griffin JD (2003) Resistance to imatinib (Glivec): update on clinical mechanisms. Drug Resist Updat 6(5):231–238

    Article  PubMed  CAS  Google Scholar 

  • Yip YL, Scheib H, Diemand AV, Gattiker A, Famiglietti LM, Gasteiger E, Bairoch A (2004) The Swiss-Prot variant page and the ModSNP database: a resource for sequence and structure information on human protein variants. Hum Mutat 23(5):464–470

    Article  PubMed  CAS  Google Scholar 

  • Yip YL, Famiglietti M, Gos A, Duek PD, David FP, Gateau A, Bairoch A (2008) Annotating single amino acid polymorphisms in the UniProt/Swiss-Prot knowledgebase. Hum Mutat 29(3):361–366

    Article  PubMed  CAS  Google Scholar 

  • Yuan Z, Bailey TL, Teasdale RD (2005) Prediction of protein B-factor profiles. Proteins 58(4):905–912

    Article  PubMed  CAS  Google Scholar 

  • Zhang C, Vasmatzis G, Cornette JL, DeLisi C (1997) Determination of atomic desolvation energies from the structures of crystallized proteins. J Mol Biol 267(3):707–726

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors thank the management of Vellore Institute of Technology for providing the facilities to carry out this work.

Author information

Authors and Affiliations

  1. Bioinformatics Division, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India

    R. Rajasekaran & Rao Sethumadhavan

Authors
  1. R. Rajasekaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rao Sethumadhavan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rao Sethumadhavan.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 253 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rajasekaran, R., Sethumadhavan, R. Exploring the cause of drug resistance by the detrimental missense mutations in KIT receptor: computational approach. Amino Acids 39, 651–660 (2010). https://doi.org/10.1007/s00726-010-0486-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-010-0486-6

Keywords

Search

Navigation